https://www.avient.com/sites/default/files/2025-02/Hammerhead FR Flame Retardant Composite Panel for Building _ Construction Product Overview.pdf
Visit avient.com or
connect with us now
Property Unit Hammerhead Composite
Panel (non-FR)
Hammerhead FR
Flame Retardant Panel
Areal Weight (lb/sqft) 1.15 1.34
Thickness (in) 1.02 1.02
Max Force* (lbf) 447 508
Modulus* (ksi) 323 321
Flexural Rigidity* (lb*in^2) 85,000 84,000
R-Value (/in) 4 4
MECHANICAL PROPERTIES
* ASTM D7249, 22” support span 4-point bend
Hammerhead FR Flame Retardant Panel
Panel Thickness 1 in. 4 in.
https://www.avient.com/sites/default/files/2021-03/in-house-plastisol-program-bulletin.pdf
If you are producing 1 million
pounds of plastisol annually, you are also losing
1,300 pounds of resin into the air.
https://www.avient.com/sites/default/files/2020-08/wilflex-ghosting-tips-techniques.pdf
In order for ghosting to occur, these 5 factors must
co-exist.
1.
https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Antimony Trioxide.pdf
CATEGORY DETAIL
EC Number 215-175-0
CAS Number 1309-64-4
Name Subclass 1 Antimony Trioxide (ATO)
Structural Formula
CHEMICAL IDENTITY
PROPERTY DETAIL
Physical State Solid
Form Powder
Color White
Odor Odorless
Melting Point 656°C
Boiling Point 1425°C
Bulk Density 5.20 g/cm3
Water Solubility Slightly Soluble
PHYSICAL/
CHEMICAL
PROPERTIES
HEALTH EFFECTS
HUMAN HEALTH SAFETY ASSESSMENT
Consumer
It is very unlikely that consumers would be exposed to ATO in its concentrated
form because it is only sold for industrial use to make polymers and other products
and is not sold directly to consumers.
https://www.avient.com/sites/default/files/2022-08/MEVOPUR Special Effect Colors Application Bulletin_CN.pdf
主要特性
在三个经ISO 13485认证的生产设施生产,在
全球范围内提供质量稳定一致的产品,并增加
供应稳定性
变更控制记录的级别高于CAS编号级别,降低
变更风险
不含动物源性物质和邻苯二甲酸盐
可用作预着色配方或母粒,用于不同的聚合物
注册药品管理档案(III类)和/或医疗器械主
文件
食品接触符合FDA/EU**要求
法规支持
原材料根据以下标准检测:
- ISO 10993-1和美国药典 生物学
评估
- 欧洲药典3.1.3/3.1.5(聚烯烃)
- 美国药典(聚乙烯)
- ICH Q3D 杂质元素
* 设计备注:选择效果颜色时需要仔细考虑零件设计和聚合物流动路径,
从而尽可能减少可见流线。
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2020-10/sem-base-station-antenna-application-bulletin-jp.pdf
Avient は、指定された比誘電率( Dk)の材料を1週間でサンプル試作することができ、2~3週間で工場スケールで製 造し、出荷することができます。
ベース樹脂 誘電率(Dk) ET7600- 8031 ET7600- 8027 ET7600- 8025 ET7600- 8037 ET7600- 8019 ET7600- 8028 ET7600- 8026 ET7600- 8044 ET7600- 8029 ET7600- 8041 ET7600- 8045 ET7600- 8036 PPE PPE PPE PPE PPE PPE PPE PPE PPE PPE PPE PPE 3.0 3.1 3.35 3.6 3.8 4.4 4.8 5.28 5.4 5.85 7.0 9.0 EDGETEK TM EDGETEK TM Avient のカスタマイズされた材料設計は、5G基地局のアンテナの進化にどのような優位性をもたらすか 素早い仕様決定と、短いリードタイム - PolyOne は1 週間以内で指定されたDk値でサンプルを試作し、2~3 週間以内に工場スケールで製品をお届けします。
https://www.avient.com/sites/default/files/2025-04/Supplier Code of Conduct FV_Port.pdf
Estão disponíveis informações adicionais
em https://www.cbp.gov/trade/forced-labor
https://www.avient.com/sites/default/files/2023-07/Versaflex HC _ Versaflex HC BIO - BT Series Product Overview.pdf
KEY CHARACTERISTICS
• Meets critical need for thermal weldability
and kink resistance
• Minimizes extractables during processing
• Provides excellent tensile strength
• Complies with USP VI and ISO 10993-4, -5, -11
certifications
• Suitable for gamma and autoclave
sterilization methods
• Bio-based grade option formulated with nearly
40% Gen 1 biomass content
PRODUCT OVERVIEW
1.844.4AVIENT
www.avient.com
Copyright © 2023, Avient Corporation.
https://www.avient.com/sites/default/files/resources/POL%2520Credit%2520Suisse%2520IR%2520Presentation%2520w%2520non-GAAP%25209%252017%25202013.pdf
Use of Non-GAAP Measures
Page 3
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500
Strategy and Execution Drive Results
Page 4
All time closing high of
$29.48
August 1, 2013
• 15 consecutive quarters of
double digit EPS growth
• 42% CAGR adjusted EPS
expansion 2006-2012
• YTD stock price has
increased 42% versus 20%
growth in the S&P
• 275% increase in market cap:
$0.7b $2.6b since 2006
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Four Pillar Strategy
Page 5
PP&S
15%
Specialty
Distribution
25%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010* 2011* 2012* 2015
Target
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
ha
re
Appliance
6%
Building &
Construction
13%
Wire & Cable
Electrical &
Electronics
4%
Consumer
Packaging
18%
Industrial
10%
Misc.
5%
HealthCare
Transportation
16%
Textiles
1%
United
States
70%
Europe
14%
Canada
8%
Asia
5%
Latin
America
3%
2012 Revenues: $4.0 Billion*
End Markets*
2012 Revenues: $4.0 Billion*
EPS
Page 6
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations
PolyOne
At A Glance
* Restated to exclude discontinued operations
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
**Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes discontinued operations
2%
34% 43% 45%
60%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2012 2012 PF** 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $87M $114M $150M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 H1 2013 2015
Where we were Where we are
Organic Consolidated
Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.7% 12.6% 12 – 16%
Global Specialty Engineered
Materials 1.1% 10.9% 9.2% 12 – 16%
Designed Structures & Solutions — — 4.4% 8 – 10%
Performance Products &
Solutions 5.4% 8.1% 8.2% 9 – 12%
Distribution 2.6% 6.1% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 26%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
*Percentage of Specialty Platform revenue from products introduced in last five years
19.5%
46.5%
2006 Q2 2013
$20.3
$44.7
2006 TTM
Q2'13
14.3%
31.1%
2006 Q2 2013
Research & Development
Spending
Specialty Platform
Vitality Index Progression*
Innovation Drives Earnings Growth
($ millions)
Specialty Platform
Gross Margin %
Page 9
We are Experts in Polymer Science and Formulation
Polymer Science
Formulation
Chemistry
Processing
Inputs
Base Resins
Additives
Modifiers
Colorants
Specialized
Polymer Materials,
Services, and Solutions
Expertise
Satisfied
Consumers
PolyOne Customer
Innovative
Products & Services
Marketplace Demands
Performance Requirements
Value Drivers
Page 10
Positioned for Strong Growth
2015 Target
Rev: $5B
Adj.
https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
Use of Non GAAP Measures
Page 3
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500
Strategy and Execution Drive Results
Page 4
All time closing high of
$29.48
August 1, 2013
• 15 consecutive quarters of
double digit EPS growth
• 42% CAGR adjusted EPS
expansion 2006-2012
• YTD stock price has
increased 42% versus 20%
growth in the S&P
400% increase in market cap,
from $0.7b to $2.8b since
2006
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Four Pillar Strategy
Page 5
PP&S
15%
Specialty
60%
Distribution
25%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010* 2011* 2012* 2015
Target
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
ha
re
Appliance
6%
Building &
Construction
13%
Wire & Cable
Electrical &
Electronics
4%
Consumer
Packaging
18%
Industrial
10%
Misc.
5%
HealthCare
Transportation
16%
Textiles
1%
United
States
70%
Europe
14%
Canada
8%
Asia
5%
Latin
America
3%
2012 Revenues: $4.0 Billion*
End Markets*
2012 Revenues: $4.0 Billion*
EPS
Page 6
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations
PolyOne
At A Glance
* Restated to exclude discontinued operations
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
**Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes discontinued operations
2%
34% 43% 45%
60% 62%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2012 2012 PF** H1'13 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $87M $114M $150M $98M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 H1 2013 2015
Where we were Where we are Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.6% 12 – 16%
Global Specialty Engineered
Materials 1.1% 9.2% 12 – 16%
Designed Structures & Solutions -- 4.4% 8 – 10%
Performance Products &
Solutions 5.4% 8.3% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 26% Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
*Percentage of Specialty Platform revenue from products introduced in last five years
11.5%
46.5%
2006 Q2 2013
$20.3
$44.7
2006 TTM
Q2'13
14.3%
31.1%
2006 Q2 2013
Research & Development
Spending
Specialty Platform
Vitality Index Progression*
Innovation Drives Earnings Growth
($ millions)
Specialty Platform
Gross Margin %
Page 9
We are Experts in Polymer Science and Formulation
Polymer Science
Formulation
Chemistry
Processing
Inputs
Base Resins
Additives
Modifiers
Colorants
Specialized
Polymer Materials,
Services, and Solutions
Expertise
Satisfied
Consumers
PolyOne Customer
Innovative
Products & Services
Marketplace Demands
Performance Requirements
Value Drivers
Page 10
Positioned for Strong Growth
2015 Target
Rev: $5B
Adj.